Tolvaptan

Catalog No.S2593 Synonyms: OPC-41061

Tolvaptan Chemical Structure

Molecular Weight(MW): 448.94

Tolvaptan is an orally effective nonpeptide arginine vasopressin V2 receptor antagonist with IC50 of 3 nM, used to treat hyponatremia.

Size Price Stock Quantity  
In DMSO USD 200 In stock
USD 150 In stock
USD 470 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

1 Customer Review

  • Immunoblots of inner medullas from control and tolvaptan-treated rats. Each lane was loaded with a sample from a different rat. Tolvaptan (2.5 mg/day) or vehicle was infused for 4 days. Loading: aquaporin-2 (AQP2), 15 μg; AQP3, 20 μg; AQP4, 25 μg; and urea transporter UT-A1, 25 μg. Values are normalized band densities covering all bands (means ± SE). *Statistical significance (P < 0.05, t-test).

    Am J Physiol Renal Physiol 2014 306(3), F359-66. Tolvaptan purchased from Selleck.

Purity & Quality Control

Choose Selective Vasopressin Receptor Inhibitors

Biological Activity

Description Tolvaptan is an orally effective nonpeptide arginine vasopressin V2 receptor antagonist with IC50 of 3 nM, used to treat hyponatremia.
Targets
vasopressin receptor 2 [4]
3 nM
In vitro

Tolvaptan blocks the binding of [(3)H]AVP to human V(2) receptors with 29-fold greater selectivity than that for V(1a) receptors, and showed no inhibition of V(1b) receptors. Tolvaptan inhibits not only the binding of [(3)H]AVP but also the AVP-induced production of cyclic AMP in human V(2)-receptor-expressing HeLa cells. Tolvaptan shows marked aquaresis in healthy and diseased animals. [1] Tolvaptan causes a concentration-dependent inhibition of arginine vasopressin-induced cAMP production with an apparent IC(50) of 0.1 nM in autosomal dominant polycystic kidney disease (ADPKD) cells. Tolvaptan inhibits AVP-induced ERK signaling and cell proliferation. Tolvaptan inhibits AVP-induced Cl(-) secretion and decreases in vitro cyst growth of ADPKD cells cultured within a three-dimensional collagen matrix. [2]

In vivo Tolvaptan improves hyponatremia, resulting in the prevention of death, and improves organ water retention in rat models with acute and chronic hyponatremia. Tolvaptan reduces cardiac preload without unfavorable effects on renal functions, systemic hemodynamics, or circulating neurohormones in dogs with heart failure (HF). Tolvaptan shows a decrease in kidney weight as well as in cyst and fibrosis volume in animal models of human polycystic kidney disease (PKD). [1] Tolvaptan markedly elevates electrolyte-free water clearance (E-CH(2)O) or aquaresis to a positive value and increases urinary Arginine vasopressin (AVP) excretion in rats with heart failure. [3]

Protocol

Solubility (25°C)

In vitro DMSO 89 mg/mL (198.24 mM)
Ethanol 6 mg/mL (13.36 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 448.94
Formula

C26H25ClN2O3

CAS No. 150683-30-0
Storage powder
Synonyms OPC-41061

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03048747 Recruiting Syndrome of Inappropriate Antidiuretic Hormone Secretion Otsuka Pharmaceutical Co., Ltd. January 2017 Phase 3
NCT02994394 Recruiting Healthy Adult Male Otsuka Pharmaceutical Co., Ltd. December 2016 Phase 1
NCT02959411 Recruiting Heart Failure|Hyponatremia University of Calgary|Otsuka Canada Pharmaceutical Inc. October 2016 Phase 4
NCT02538016 Not yet recruiting Cystinuria Caleb Nelson|Otsuka America Pharmaceutical|Boston Children’s Hospital October 2016 --
NCT02964273 Recruiting Autosomal Dominant Polycystic Kidney Disease (ADPKD) Otsuka Pharmaceutical Development & Commercialization, Inc. September 2016 Phase 3
NCT02666651 Recruiting Decompensated Heart Failure|Hyponatremia Cardiology Research UBC May 2016 Phase 4

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Vasopressin Receptor Signaling Pathway Map

Tags: buy Tolvaptan | Tolvaptan ic50 | Tolvaptan price | Tolvaptan cost | Tolvaptan solubility dmso | Tolvaptan purchase | Tolvaptan manufacturer | Tolvaptan research buy | Tolvaptan order | Tolvaptan mouse | Tolvaptan chemical structure | Tolvaptan mw | Tolvaptan molecular weight | Tolvaptan datasheet | Tolvaptan supplier | Tolvaptan in vitro | Tolvaptan cell line | Tolvaptan concentration | Tolvaptan nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID